On the icephobicity of damage-tolerant superhydrophobic bulk nanocomposites.

To address the increase in demand for superhydrophobic and icephobic surfaces with greater mechanical robustness, we fabricated damage-tolerant, abrasion-insensitive, and icephobic superhydrophobic bulk nanocomposites using a facile, cost-effective, industrially applicable, and environmentally benign strategy. We prepared nanocomposites composed of high-temperature vulcanized silicone rubber through the highly controlled incorporation of nanosized fumed silica and microsized aluminum trihydrate particles. The produced nanocomposites did not require additional processing, such as sand abrasion or plasma treatment, to acquire their superhydrophobic properties. The extended roughness throughout the whole bulk of the nanocomposites imparted the volumetric superhydrophobicity and resistance to mechanical damage. The presence of micro-nanoparticles also enhanced the thermal stability and icephobic properties of the silicone rubber. The icephobic behavior of the developed nanocomposites was assessed based on freezing delay and push-off tests both of which denoted improved icephobic properties, i.e., high freezing delay time and low ice adhesion strength. We verified the extended duration of superhydrophobicity within the bulk nanocomposite using sandpaper abrasion, severe cutter scratching, tape peeling, and water-jet impacts. This study represents the first evaluation, to the best of our knowledge, of the icephobic properties of both the surface and bulk of the produced nanocomposite subjected to several cycles of sandpaper abrasion. Interestingly, even after multiple abrasion cycles, the samples demonstrated considerably low ice adhesion strength confirming their bulk icephobicity. In a nutshell, our findings are very promising for the fabrication of mechanically robust icephobic materials.

Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat.

Alpha2 adrenergic agonists are used in the anesthetic management of the surgical patient for their sedative/hypnotic properties although the alpha2 adrenoceptor subtype responsible for these anesthetic effects is not known. Using a gene-targeting strategy, it is possible to specifically reduce the expression of the individual adrenoceptors expressed in the central nervous system and to thereby determine their role in hypnotic action. Stably transfected cell lines (PC 124D for rat alpha2A; NIH3T3 for rat alpha2C adrenoceptors) were exposed to 5 microM antisense oligodeoxynucleotides (ODNs) for alpha2A and alpha2C adrenergic receptor subtypes for 3 d. Individual receptor subtype expression, as determined by radiolabeled ligand binding, was selectively decreased only by the appropriate antisense ODNs and not by the "scrambled" ODNs. These antisense ODNs were then administered three times, on alternate days, into the locus coeruleus of chronically cannulated rats and their hypnotic response to dexmedetomidine (an alpha2 agonist) was determined. Only the alpha2A antisense ODNs significantly change the hypnotic response causing both an increase in latency to, and a decrease in duration of, the loss of righting reflex following dexmedetomidine; hypnotic response had normalized 8 d after stopping the ODNs. Therefore, the alpha2A adrenoceptor subtype is responsible for the hypnotic response to dexmedetomidine in the locus coeruleus of the rat.